Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Ana María Celis, MD"'
Autor:
Julián Londoño, MD, Lucia Perez, MD, Sergio Moreno, MSc, Edgardo Chapman, MD, María Beatriz Garcia, MD, Ana María Celis, MD, María Angélica Muñoz, MD, David Castillo, MD, Jorge Sánchez, MD, Yaicith Arevalo, MD, Ana Lozano, MD, MSc, Nelson J. Alvis-Zakzuk, MSc, Cesar Muñoz, MD, MSc, Laura Botero, Catalina Beltran, MD, Elizabeth García, MD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 4, Pp 100763- (2023)
Background: Dupilumab is a treatment approved for uncontrolled moderate-to-severe atopic dermatitis (AD). Tropical and developing countries such as Colombia have characteristics that may impact the natural history of AD and access to medical treatmen
Externí odkaz:
https://doaj.org/article/346a09de88d0491985a0661adcef52b7
